Literature DB >> 7397966

Apolipoprotein A-I, A-II and C-II in black and white residents of Evans County.

H A Tyroler, G Heiss, G Schonfeld, G Cooper, S Heyden, C G Hames.   

Abstract

Plasma levels of lipids, lipoprotein-cholesterol and three major apolipoproteins (ApoA-I, A-II and C-II) were studied in 318 black and white males and females randomly sampled in Evans County, Georgia. Black-white differences in lipid and lipoprotein-cholesterol concentrations were observed, with low-density fractions higher in whites and high-density fractions higher in blacks. Plasma levels of ApoA-I but not ApoA-II were higher in blacks than in whites and in females than in males. ApoC-II concentrations were lower in black than in white men and women. Black-white differences in atherogenic lipoprotein fractions were statistically explained (in the sense of association, not necessarily of causal process) by the differences in ApoC-II concentrations between the race groups. Black-white differences in anti etherogenic high-density lipoprotein-cholesterol were greater than statistically predicted by differences in ApoA lipoprotein levels. The findings are indicative of black-white differences in lipoprotein composition.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7397966     DOI: 10.1161/01.cir.62.2.249

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  5 in total

Review 1.  The lipoproteins: predictors, protectors, and pathogens.

Authors:  B Lewis
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-22

2.  Tangier disease: heterozygote detection and linkage analysis.

Authors:  B K Suarez; G Schonfeld; R S Sparkes
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

3.  Associations between lipoprotein(a) levels and cardiovascular outcomes in black and white subjects: the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Salim S Virani; Ariel Brautbar; Brian C Davis; Vijay Nambi; Ron C Hoogeveen; A Richey Sharrett; Josef Coresh; Thomas H Mosley; Joel D Morrisett; Diane J Catellier; Aaron R Folsom; Eric Boerwinkle; Christie M Ballantyne
Journal:  Circulation       Date:  2011-11-29       Impact factor: 29.690

4.  Familial apolipoprotein E deficiency.

Authors:  E J Schaefer; R E Gregg; G Ghiselli; T M Forte; J M Ordovas; L A Zech; H B Brewer
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

5.  Improvement of High-Density Lipoprotein Function in Patients With Early Rheumatoid Arthritis Treated With Methotrexate Monotherapy or Combination Therapies in a Randomized Controlled Trial.

Authors:  Christina Charles-Schoeman; Yuen Yin Lee; Ani Shahbazian; Xiaoyan Wang; David Elashoff; Jeffrey R Curtis; Iris Navarro-Millán; Shuo Yang; Lang Chen; Stacey S Cofield; Larry W Moreland; Harold Paulus; James O'Dell; Joan Bathon; S Louis Bridges; Srinivasa T Reddy
Journal:  Arthritis Rheumatol       Date:  2017-01       Impact factor: 15.483

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.